Jovan-Embiricos Morana
SEC CIK 1575745 · EDGAR
BoughtSold
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Jovan-Embiricos Morana made no open-market trades at KLRS in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-07 | 2024-06-06 | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir, 10% | A - Grant | $0.00 | +35.0K | 100.2K | +54% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir, 10% | A - Grant | $0.00 | +35.0K | 65.2K | +116% | $0 | |
| M | 2022-08-04 | 2022-08-02+ | CGEM | Cullinan Therapeutics, Inc. | Jovan-Embiricos Morana | 10% | S - Sale | $14.26 | -49.9K | 1.28M | -4% | -$711.9K |
| MI | 2022-08-01 | 2022-07-28 | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir, 10% | A - Grant | $4.61 | +8.15M | 2.06M | New | +$37.58M |
| D | 2022-06-28 | 2022-06-24 | CGEM | Cullinan Therapeutics, Inc. | Jovan-Embiricos Morana | 10% | F - Tax | $13.39 | -45.1K | 207.8K | -18% | -$603.6K |
| DM | 2022-06-28 | 2022-06-24 | CGEM | Cullinan Therapeutics, Inc. | Jovan-Embiricos Morana | 10% | M - OptEx | $4.30 | +140.4K | 252.9K | +125% | +$603.6K |
| 2022-01-13 | 2022-01-11 | CGEM | Cullinan Therapeutics, Inc. | Jovan-Embiricos Morana | 10% | J - Other | — | -1.19M | 1.72M | -41% | — | |
| MI | 2021-11-15 | 2021-11-10 | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir | S - Sale | $24.77 | -800 | 342.7K | -0.2% | -$19.8K |
| MI | 2021-11-09 | 2021-11-05+ | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir | S - Sale | $24.80 | -12.2K | 1.38M | -0.9% | -$302.4K |
| MI | 2021-10-29 | 2021-10-27 | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir | S - Sale | $24.78 | -2,200 | 1.39M | -0.2% | -$54.5K |
| MI | 2021-10-25 | 2021-10-21+ | KLRS | Kalaris Therapeutics, Inc. | Jovan-Embiricos Morana | Dir | S - Sale | $24.80 | -13.6K | 1.39M | -1.0% | -$337.1K |
Purchase Sale Sale after option exercise All abbreviations